🇺🇸 Relmada Therapeutics, Inc.
Forum topic · RLMD · Company page: financials, ownership and filings
Join the discussion on Relmada Therapeutics, Inc.
Loading…
Results announced on 12 November 2026
Relmada Therapeutics, Inc. announced results on 12 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: a net loss of $14 million.
Mutual funds: 71 funds hold $92 million
71 mutual funds in 1 country hold shares of Relmada Therapeutics, Inc. worth $92 million, about 13.0% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 64 funds added shares and 2 sold; on balance they bought $65 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.